EN
登录

人工智能在呼吸系统疾病市场蓬勃发展,预计到2031年将以29.4%的复合年增长率增长

AI in Respiratory Diseases Market is Booming and Expected to Grow at a CAGR of 29.4% to 2031

GlobeNewswire 等信源发布 2023-09-26 17:05

可切换为仅中文


Jersey City, NJ,, Sept. 26, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the 'Global AI in Respiratory Diseases Market- (By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By Imaging Type (MRI, CT Scan, ePRO), By End-use (Hospital, Diagnostic Centers, Ambulatory Surgical centers, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.' According to the latest research by InsightAce Analytic, the Global AI in Respiratory Diseases Market is expected to show a CAGR of 29.4% during a forecast period of 2023-2031.

新泽西州新泽西市,2023年9月26日(GLOBE NEWSWIRE)-InsightAce Analytic Pvt。Ltd.宣布发布关于'全球呼吸系统疾病市场AI'的市场评估报告-(通过适应症(慢性阻塞性肺病),间质性肺病,肺部感染),成像类型(MRI,CT扫描,ePRO),最终用途(医院,诊断中心,门诊手术中心等)),趋势,行业竞争分析,收入和预测到2031年。根据InsightAce Analytic的最新研究,预计全球呼吸系统疾病人工智能市场在2023-2031年的预测期内将显示29.4%的CAGR。

AI (Artificial Intelligence) has made significant strides in diagnosing, managing, and researching respiratory diseases, offering innovative solutions to improve patient care and outcomes. Diagnostic techniques for respiratory illnesses are typically used to identify and treat respiratory problems at their earliest, most treatable stages.  Free PDF Report Brochure @ https://www.insightaceanalytic.com/request-sample/2055 AI in Respiratory Diseases Market expansion is driven by the importance of high-resolution CT in diagnosing fibrotic Lung illness.

AI(人工智能)在诊断,管理和研究呼吸系统疾病方面取得了重大进展,为改善患者护理和结果提供了创新的解决方案。呼吸系统疾病的诊断技术通常用于在最早,最可治疗的阶段识别和治疗呼吸系统疾病。免费PDF报告手册@https://www.insightaceanalytic.com/request-sample/2055AI在呼吸系统疾病中的市场扩张是由高分辨率CT在诊断纤维化肺病中的重要性所驱动的。

Idiopathic pulmonary fibrosis can be diagnosed without a lung biopsy if a high-resolution CT scan shows signs that are similar to those of normal interstitial pneumonia. In addition, because the number of people suffering from chronic diseases and breathing problems continues to rise, the application of AI to the treatment of respiratory ailments is rapidly growing in popularity around the world.

如果高分辨率CT扫描显示与正常间质性肺炎相似的体征,则可以在没有肺活检的情况下诊断特发性肺纤维化。此外,由于患有慢性病和呼吸问题的人数持续增加,人工智能在呼吸系统疾病治疗中的应用在世界各地迅速普及。

An extraordinary boom in the volume and complexity of healthcare-related data is being generated by the emergence of new digital tools, particularly in areas like genomics, diagnostic i.

新的数字工具的出现,特别是在基因组学,诊断学等领域,正在产生医疗保健相关数据量和复杂性的非凡繁荣。